Michaels v. Michaels’s Stores Procurement Company, Inc. , 2016 FCA 88 (les juges Noël, Stratas et Rennie)

Emerson Electric Co. et al. v. Canadian Tire Corporation, Limited, 2016 FC 308 (le juge Annis)

Sadhu Singh Hamdard Trust v. Navsun Holdings Ltd. Master Web Inc. et 6178235 Canada Inc., 2016 FCA 69 (les juges Pelletier, Stratas et Gleason)

Ty Inc. v. Promotions C.D. Inc. , 2016 FC 259 (le juge Barnes)

MC Imports Ltd. c. AFOD Ltd., 2016 CAF 60 (les juges Trudel, Scott et de Montigny)

Brown c. Canada, 2016 CAF 37 (les juges Webb, Boivin et de Montigny)

Rogers Communications Partnership v. Société canadienne des auteurs, compositeurs et éditeurs de musique (également connue sous l’acronyme SOCAN), 2016 FCA 28 (les juges Ryer, Webb et Near)

This Order and Reasons dealt with a motion that was brought by Bayer in the context of a judicial review, which circumstances may be summarized as follows: On August 22, 2023, Bayer made a submission to the Office of Patented Medicines and Liaison (the “OPML”) to list Canadian Patent No. 2,970,315 (the “315 Patent”) on the Patent Register in respect of the product EYLEA®, but the eligibility decision was not made until August 30, 2023;

This Order and Reasons dealt with a motion brought by the plaintiffs (Janssen Inc. and Mitsubishi Tanabe Pharma Corporation, collectively, “Janssen”) for an order requiring the defendant (JAMP Pharma Corporation) to produce certain samples. The motion was brought in the context of an action brought by Janssen under the Patented Medicines (Notice of Compliance) Regulations involving the medicinal ingredient canagliflozin.

Nia Wine Group Co., Ltd. v. North 42 Degrees Estate Winery Inc., 2022 FC 241